Redmile Group, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RAPT
Shares outstanding
17,831,343 shares
Disclosed Ownership
1,765,303 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:18:11 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 1,765,303 0 1,765,303 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 1,765,303 0 1,765,303 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 6.5% 1,147,390 0 1,147,390 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.